Summary: Avadel Pharmaceuticals plc announced the publication of final data from the RESTORE open-label/switch study, which demonstrated a strong preference among people with narcolepsy for the once-nightly Lumryz over a twice-nightly immediate-release oxybate. Lumryz, approved … [Read more...]